J Clin Outcomes Manage
Persistence patterns with oral hypoglycemic agents in type 2 diabetes
Stephens JM, Blak BT, Gold KF, Botteman MF, Pashos Cl, Walkinshaw CS, Campbell RK
Overall persistence with oral hypoglycemic drug treatment appears to be low in type 2 diabetes and differs within gender, age, and individual drug categories. The largest differences in persistence were seen across drug therapies, underscoring the importance of careful selection of an initial hypoglycemic agent.
Search the Turner White index to find abstracts of articles published in JCOM.